Abstract
Despite extensive quantities of work with regard to reactivation of organophosphorus-inhibited and aged acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), a new therapeutic solution has yet to be reached and current methods continue to rely on old oximes and management of the cholinergic crisis as the standard of care. For more information on the latest developments in this highly important field see the Review article by C. M. Hadad et al. on page 5337 ff.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
